# FDA Inspection 786051 - The Blood Center of New Jersey - June 12, 2012

Source: https://www.keypedia.com/records/fda_inspections/the-blood-center-of-new-jersey/4065a2da-78d4-4e73-aa74-2a7fd3bfa960
Source feed: FDA_Inspections

> FDA Inspection 786051 for The Blood Center of New Jersey on June 12, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 786051
- Company Name: The Blood Center of New Jersey
- Inspection Date: 2012-06-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 852220 - 2013-10-22](https://www.keypedia.com/records/fda_inspections/the-blood-center-of-new-jersey/705bf5b6-6d44-4fd7-91e4-a456cf439eb5)
- [FDA Inspection 707137 - 2011-01-25](https://www.keypedia.com/records/fda_inspections/the-blood-center-of-new-jersey/534393c9-e216-4d1c-a8bb-e6b7f4d953a6)
- [FDA Inspection 571357 - 2009-03-17](https://www.keypedia.com/records/fda_inspections/the-blood-center-of-new-jersey/d0bb1555-c7be-4fcd-ac1b-de3d899a81cf)

Company: https://www.keypedia.com/companies/the-blood-center-of-new-jersey/7dbc2a8e-cf61-47e2-a68d-3025dcfd484d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d